About Oculeve
Oculeve is a company based in San Francisco (United States) founded in 2011.. Oculeve has raised $24.94 million across 4 funding rounds from investors including Kleiner Perkins, NEA and Versant Ventures. The company has 19 employees as of December 31, 2015. Oculeve operates in a competitive market with competitors including TearScience, Tear Film Innovations, Bruder Healthcare, Olympic Ophthalmics and Sinopsys Surgical, among others.
- Headquarter San Francisco, United States
- Employees 19 as on 31 Dec, 2015
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oculeve, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$24.94 M (USD)
in 4 rounds
-
Latest Funding Round
$16.65 M (USD), Series B
Mar 18, 2014
-
Investors
Kleiner Perkins
& 3 more
-
Employee Count
19
as on Dec 31, 2015
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Oculeve
Oculeve has successfully raised a total of $24.94M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $16.65 million completed in March 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series B — $16.6M
- First Round First Round
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2014 | Amount | Series B - Oculeve | Valuation |
investors |
|
| Mar, 2013 | Amount | Series A - Oculeve | Valuation |
investors |
|
| Aug, 2012 | Amount | Seed - Oculeve | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oculeve
Oculeve has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Kleiner Perkins, NEA and Versant Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Founded Year | Domain | Location | |
|
Venture capital firm managing investments in biotechnology and pharmaceuticals since 1999.
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in early-stage tech startups
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oculeve
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oculeve
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oculeve Comparisons
Competitors of Oculeve
Oculeve operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as TearScience, Tear Film Innovations, Bruder Healthcare, Olympic Ophthalmics and Sinopsys Surgical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Devices for evaporative dry eye diagnosis and treatment are developed.
|
|
| domain | founded_year | HQ Location |
Evaporative dry eye is treated through meibomian gland stimulation devices.
|
|
| domain | founded_year | HQ Location |
Solutions for dry eye and pain management are developed.
|
|
| domain | founded_year | HQ Location |
Provider and developer of tear production device for treatments of dry eye disease
|
|
| domain | founded_year | HQ Location |
Offers lacrimal stents and procedures designed to effectively treat sinusitis.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oculeve
Frequently Asked Questions about Oculeve
When was Oculeve founded?
Oculeve was founded in 2011.
Where is Oculeve located?
Oculeve is headquartered in San Francisco, United States. It is registered at San Francisco, California, United States.
Is Oculeve a funded company?
Oculeve is a funded company, having raised a total of $24.94M across 4 funding rounds to date. The company's 1st funding round was a Seed of $700K, raised on Jun 01, 2010.
How many employees does Oculeve have?
As of Dec 31, 2015, the latest employee count at Oculeve is 19.
What does Oculeve do?
Oculeve is developing a treatment for dry eye disease. Its technology was conceptualized at Stanford University in a collaboration between the Departments of Biodesign and Ophthalmology. Its lead product is a non-invasive nasal neurostimulation device that increases tear production in patients with dry eye disease. The company was acquired by Allergan in July 2015 for a 125M upfront payment and milestone payments related to its lead development program.
Who are the top competitors of Oculeve?
Oculeve's top competitors include Tear Film Innovations, TearScience and Bruder Healthcare.
Who are Oculeve's investors?
Oculeve has 4 investors. Key investors include Kleiner Perkins, NEA, Versant Ventures, and Stanford Biodesign.